Assignee
OISIN BIOTECHNOLOGIES INC
US·2 granted patents·7 pending applications·3 citations·filing 2018–2025
Top patents by PatentIndex Score
9 records- 0180US11603543B2Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic proteinOISIN BIOTECHNOLOGIES INC·Filed 2019·Granted Mar 14, 2023·2 cites·28 claims
- 0276US2024382623A1Systems and methods for the targeted production of a therapeutic protein within a target cellOISIN BIOTECHNOLOGIES INC·Filed 2024·Application pending·0 cites
- 0373US2024374760A1Compositions and methods for liver-specific expression of follistatinOISIN BIOTECHNOLOGIES INC·Filed 2024·Application pending·0 cites
- 0472US2023348937A1Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein fusogenic lipid nanoparticles and methods of manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a diseaseOISIN BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 0568US11525146B2Expression constructs, fusogenic lipid-based nanoparticles and methods of use thereofOISIN BIOTECHNOLOGIES INC·Filed 2018·Granted Dec 13, 2022·1 cites·27 claims
- 0666US2023220422A1Fusogenic lipid nanoparticles and methods for the manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a disease, condition, or disorder associated with a target cellOISIN BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 0765US2020009268A1Expression constructs and systems for systemic and non-specific in vivo delivery of a nucleic acid to human cells and transient target cell-specific production of a therapeutic proteinOISIN BIOTECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 0862US2025346925A1Fusogenic lipid nanoparticles and methods for the manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a diseaseOISIN BIOTECHNOLOGIES INC·Filed 2025·Application pending·0 cites
- 0953US2022106608A1Fusogenic lipid nanoparticles for the target cell-specific production of rapamycin inducible therapeutic proteinsOISIN BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OISIN BIOTECHNOLOGIES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →